检索结果 - Patricia Pozo‐Rosich
- Showing 1 - 20 results of 46
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials 由 Faraidoon Haghdoost, Francesca Puledda, David García-Azorín, Eva‐Maria Huessler, Roberta Messina, Patricia Pozo‐Rosich
出版 2023Revisão -
13
-
14
-
15
-
16
-
17
-
18
-
19
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population 由 Carlos Lázaro-Hernández, Edoardo Caronna, Joana Rosell‐Mirmi, Victor J Gallardo, Alicia Alpuente, Marta Torres‐Ferrús, Patricia Pozo‐Rosich
出版 2024Artigo -
20
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER stu... 由 Messoud Ashina, Michel Lantéri‐Minet, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling, Patricia Pozo‐Rosich
出版 2023Artigo
相关主题
Medicine
Migraine
Internal medicine
Psychiatry
Pediatrics
Pathology
Chronic Migraine
Alternative medicine
Clinical trial
Anesthesia
Aura
Biology
Physical therapy
Adverse effect
Disease
Intensive care medicine
Psychology
Neurology
Placebo
Randomized controlled trial
Receptor
Surgery
Calcitonin gene-related peptide
Coronavirus disease 2019 (COVID-19)
Gene
Genetics
Infectious disease (medical specialty)
Neuropeptide
Tolerability
Anesthesiology